CARDIOLOGY

Psychosocial and Functional Outcomes Among Tetralogy of Fallot Survivors in the Congenital Heart Disease Project to Understand Lifelong Survivor Experience

Aug 8, 2026 by in CARDIOLOGY Comments Off on Psychosocial and Functional Outcomes Among Tetralogy of Fallot Survivors in the Congenital Heart Disease Project to Understand Lifelong Survivor Experience
As survival improves for adults with tetralogy of Fallot (TOF), long-term outcomes have taken on greater importance. We aimed to compare the long-term health, socioeconomic, and quality of life (QOL)…
read more

Revisiting Beta-Blockers in Heart Failure With Preserved Ejection Fraction—A Systematic Review and Meta-analysis

Aug 8, 2026 by in CARDIOLOGY Comments Off on Revisiting Beta-Blockers in Heart Failure With Preserved Ejection Fraction—A Systematic Review and Meta-analysis
Despite advances in device therapy and the emergence of novel treatments, beta-blockers (BBs) remain a commonly prescribed medication in heart failure (HF). However, HF with preserved ejection fraction (HFpEF) is…
read more

Characterizing Antithrombotic Regimens After Isolated Mitral Valve Repair: A Retrospective Descriptive Study and Interview of Cardiac Surgeons

Aug 8, 2026 by in CARDIOLOGY Comments Off on Characterizing Antithrombotic Regimens After Isolated Mitral Valve Repair: A Retrospective Descriptive Study and Interview of Cardiac Surgeons
The evidence for optimal antithrombotic therapy after isolated surgical mitral valve repair (MVr) is limited resulting in variable use of antithrombotic regimens in practice. This study aimed to characterize what…
read more

Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients

Aug 8, 2026 by in CARDIOLOGY Comments Off on Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients
This sub-analysis of SEQUOIA-HCM (NCT05186818) evaluated the efficacy and safety of aficamten in obstructive hypertrophic cardiomyopathy (oHCM) and very-high Valsalva left ventricular outflow tract gradients (LVOT-G). Patients with oHCM and…
read more

Interaction of Kidney Function and Dapagliflozin in Patients With Acute Heart Failure: A Pre-Specified Analysis of DICTATE-AHF

Aug 8, 2026 by in CARDIOLOGY Comments Off on Interaction of Kidney Function and Dapagliflozin in Patients With Acute Heart Failure: A Pre-Specified Analysis of DICTATE-AHF
Background Early sodium glucose co-transporter 2 inhibitor initiation during acute heart failure (AHF) acutely improves measures of diuresis. Glucosuria from dapagliflozin decreases with declining estimated glomerular filtration rate (eGFR), and…
read more

Screening of Atrial Fibrillation/Arrhythmia Events in Patients With Abnormal ECHOcardiographic Parameters: The Randomized, Prospective SAFE-ECHO Study Design and Rationale

Aug 8, 2026 by in CARDIOLOGY Comments Off on Screening of Atrial Fibrillation/Arrhythmia Events in Patients With Abnormal ECHOcardiographic Parameters: The Randomized, Prospective SAFE-ECHO Study Design and Rationale
Atrial fibrillation (AF) screening is important because AF can be paroxysmal and asymptomatic. Although AF is closely linked to certain abnormal echocardiographic parameters, these parameters have never been incorporated as…
read more

Predictors of Progression to Low Cardiac Output or Cardiogenic Shock in Patients Hospitalized for Acute Heart Failure

Aug 8, 2026 by in CARDIOLOGY Comments Off on Predictors of Progression to Low Cardiac Output or Cardiogenic Shock in Patients Hospitalized for Acute Heart Failure
During hospitalization, patients with acute heart failure (AHF) may progress to low cardiac output syndrome (LCOS) or cardiogenic shock (CS). However, the predictive factors for this evolution are not clearly…
read more
Get Clinical Tree app for offline access